List of Tables
Table 1. Molecular Cancer Therapeutics Market Trends
Table 2. Molecular Cancer Therapeutics Market Drivers & Opportunity
Table 3. Molecular Cancer Therapeutics Market Challenges
Table 4. Molecular Cancer Therapeutics Market Restraints
Table 5. Global Molecular Cancer Therapeutics Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Molecular Cancer Therapeutics Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Molecular Cancer Therapeutics Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Molecular Cancer Therapeutics Product Type
Table 9. Key Companies Time to Begin Mass Production of Molecular Cancer Therapeutics
Table 10. Global Molecular Cancer Therapeutics Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Cancer Therapeutics as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Molecular Cancer Therapeutics Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Molecular Cancer Therapeutics Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Molecular Cancer Therapeutics Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Molecular Cancer Therapeutics Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Molecular Cancer Therapeutics Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Molecular Cancer Therapeutics Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Molecular Cancer Therapeutics Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Molecular Cancer Therapeutics Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Molecular Cancer Therapeutics Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Molecular Cancer Therapeutics Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Molecular Cancer Therapeutics Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Molecular Cancer Therapeutics Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Molecular Cancer Therapeutics Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Molecular Cancer Therapeutics Sales Value by Region (2019-2024) & (%)
Table 27. Global Molecular Cancer Therapeutics Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Molecular Cancer Therapeutics Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Molecular Cancer Therapeutics Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Molecular Cancer Therapeutics Sales Value, (2025-2030) & (US$ Million)
Table 31. Phoenix Molecular Designs Basic Information List
Table 32. Phoenix Molecular Designs Description and Business Overview
Table 33. Phoenix Molecular Designs Molecular Cancer Therapeutics Products, Services and Solutions
Table 34. Revenue (US$ Million) in Molecular Cancer Therapeutics Business of Phoenix Molecular Designs (2019-2024)
Table 35. Phoenix Molecular Designs Recent Developments
Table 36. Prelude Therapeutics Basic Information List
Table 37. Prelude Therapeutics Description and Business Overview
Table 38. Prelude Therapeutics Molecular Cancer Therapeutics Products, Services and Solutions
Table 39. Revenue (US$ Million) in Molecular Cancer Therapeutics Business of Prelude Therapeutics (2019-2024)
Table 40. Prelude Therapeutics Recent Developments
Table 41. Tempus Basic Information List
Table 42. Tempus Description and Business Overview
Table 43. Tempus Molecular Cancer Therapeutics Products, Services and Solutions
Table 44. Revenue (US$ Million) in Molecular Cancer Therapeutics Business of Tempus (2019-2024)
Table 45. Tempus Recent Developments
Table 46. Bracco Basic Information List
Table 47. Bracco Description and Business Overview
Table 48. Bracco Molecular Cancer Therapeutics Products, Services and Solutions
Table 49. Revenue (US$ Million) in Molecular Cancer Therapeutics Business of Bracco (2019-2024)
Table 50. Bracco Recent Developments
Table 51. iOmx Therapeutics Basic Information List
Table 52. iOmx Therapeutics Description and Business Overview
Table 53. iOmx Therapeutics Molecular Cancer Therapeutics Products, Services and Solutions
Table 54. Revenue (US$ Million) in Molecular Cancer Therapeutics Business of iOmx Therapeutics (2019-2024)
Table 55. iOmx Therapeutics Recent Developments
Table 56. OncoDNA Basic Information List
Table 57. OncoDNA Description and Business Overview
Table 58. OncoDNA Molecular Cancer Therapeutics Products, Services and Solutions
Table 59. Revenue (US$ Million) in Molecular Cancer Therapeutics Business of OncoDNA (2019-2024)
Table 60. OncoDNA Recent Developments
Table 61. Sapience Therapeutics Basic Information List
Table 62. Sapience Therapeutics Description and Business Overview
Table 63. Sapience Therapeutics Molecular Cancer Therapeutics Products, Services and Solutions
Table 64. Revenue (US$ Million) in Molecular Cancer Therapeutics Business of Sapience Therapeutics (2019-2024)
Table 65. Sapience Therapeutics Recent Developments
Table 66. Caris Life Sciences Basic Information List
Table 67. Caris Life Sciences Description and Business Overview
Table 68. Caris Life Sciences Molecular Cancer Therapeutics Products, Services and Solutions
Table 69. Revenue (US$ Million) in Molecular Cancer Therapeutics Business of Caris Life Sciences (2019-2024)
Table 70. Caris Life Sciences Recent Developments
Table 71. Hera Biolabs Basic Information List
Table 72. Hera Biolabs Description and Business Overview
Table 73. Hera Biolabs Molecular Cancer Therapeutics Products, Services and Solutions
Table 74. Revenue (US$ Million) in Molecular Cancer Therapeutics Business of Hera Biolabs (2019-2024)
Table 75. Hera Biolabs Recent Developments
Table 76. CV6 Therapeutics Basic Information List
Table 77. CV6 Therapeutics Description and Business Overview
Table 78. CV6 Therapeutics Molecular Cancer Therapeutics Products, Services and Solutions
Table 79. Revenue (US$ Million) in Molecular Cancer Therapeutics Business of CV6 Therapeutics (2019-2024)
Table 80. CV6 Therapeutics Recent Developments
Table 81. Carrick Therapeutics Basic Information List
Table 82. Carrick Therapeutics Description and Business Overview
Table 83. Carrick Therapeutics Molecular Cancer Therapeutics Products, Services and Solutions
Table 84. Revenue (US$ Million) in Molecular Cancer Therapeutics Business of Carrick Therapeutics (2019-2024)
Table 85. Carrick Therapeutics Recent Developments
Table 86. Foundation Medicine Basic Information List
Table 87. Foundation Medicine Description and Business Overview
Table 88. Foundation Medicine Molecular Cancer Therapeutics Products, Services and Solutions
Table 89. Revenue (US$ Million) in Molecular Cancer Therapeutics Business of Foundation Medicine (2019-2024)
Table 90. Foundation Medicine Recent Developments
Table 91. Cybrexa Therapeutics Basic Information List
Table 92. Cybrexa Therapeutics Description and Business Overview
Table 93. Cybrexa Therapeutics Molecular Cancer Therapeutics Products, Services and Solutions
Table 94. Revenue (US$ Million) in Molecular Cancer Therapeutics Business of Cybrexa Therapeutics (2019-2024)
Table 95. Cybrexa Therapeutics Recent Developments
Table 96. Key Raw Materials Lists
Table 97. Raw Materials Key Suppliers Lists
Table 98. Molecular Cancer Therapeutics Downstream Customers
Table 99. Molecular Cancer Therapeutics Distributors List
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
Table 103. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Molecular Cancer Therapeutics Product Picture
Figure 2. Global Molecular Cancer Therapeutics Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Molecular Cancer Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 4. Molecular Cancer Therapeutics Report Years Considered
Figure 5. Global Molecular Cancer Therapeutics Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Molecular Cancer Therapeutics Revenue in 2023
Figure 7. Molecular Cancer Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Monoclonal Antibodies Picture
Figure 9. Small Molecule Inhibitors Picture
Figure 10. Global Molecular Cancer Therapeutics Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 11. Global Molecular Cancer Therapeutics Sales Value Market Share by Type, 2023 & 2030
Figure 12. Product Picture of Lung Cancer
Figure 13. Product Picture of Breast Cancer
Figure 14. Product Picture of Colorectal Cancer
Figure 15. Product Picture of Leukemia
Figure 16. Product Picture of Others
Figure 17. Global Molecular Cancer Therapeutics Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 18. Global Molecular Cancer Therapeutics Sales Value Market Share by Application, 2023 & 2030
Figure 19. North America Molecular Cancer Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 20. North America Molecular Cancer Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 21. Europe Molecular Cancer Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 22. Europe Molecular Cancer Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 23. Asia Pacific Molecular Cancer Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 24. Asia Pacific Molecular Cancer Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 25. South America Molecular Cancer Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 26. South America Molecular Cancer Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 27. Middle East & Africa Molecular Cancer Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 28. Middle East & Africa Molecular Cancer Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 29. Key Countries/Regions Molecular Cancer Therapeutics Sales Value (%), (2019-2030)
Figure 30. United States Molecular Cancer Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 31. United States Molecular Cancer Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 32. United States Molecular Cancer Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 33. Europe Molecular Cancer Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 34. Europe Molecular Cancer Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 35. Europe Molecular Cancer Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 36. China Molecular Cancer Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 37. China Molecular Cancer Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 38. China Molecular Cancer Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 39. Japan Molecular Cancer Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 40. Japan Molecular Cancer Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 41. Japan Molecular Cancer Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 42. South Korea Molecular Cancer Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 43. South Korea Molecular Cancer Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 44. South Korea Molecular Cancer Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 45. Southeast Asia Molecular Cancer Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 46. Southeast Asia Molecular Cancer Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 47. Southeast Asia Molecular Cancer Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 48. India Molecular Cancer Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 49. India Molecular Cancer Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 50. India Molecular Cancer Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 51. Molecular Cancer Therapeutics Industrial Chain
Figure 52. Molecular Cancer Therapeutics Manufacturing Cost Structure
Figure 53. Channels of Distribution (Direct Sales, and Distribution)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
